Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum NurExone Biologic Inc. NRXBF


Primary Symbol: V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ExoTherapy production platform and products for a global market. It is involved in the development of ExoPTEN, the first ExoTherapy-based product for acute Spinal Cord Injuries (SCI). The Company is developing treatment for the reversal or reduction of paralysis following... see more

TSXV:NRX - Post Discussion

NurExone Biologic Inc. > NurExone: Loading Exosomes with Therapeutic Molecules
View:
Post by ThesisCapital on Nov 30, 2022 10:28pm

NurExone: Loading Exosomes with Therapeutic Molecules

NurExone reported today results of a pre-clinical loading efficiency study that was completed by the Company showing that its innovative and proprietary loading technology has the potential to serve as an efficient process for loading of therapeutic molecular cargo into exosomes. In exosome-based therapies, loaded exosomes are biologically guided to target inflamed tissues to "dock" and unload their therapeutic cargo, creating a healing environment.

Read more here: 
[url=https://www.newsfilecorp.com/release/146207/NurExone-Biologic-Successfully-Demonstrates-its-PatentPending-Platform-Technology-for-Loading-Exosomes-with-Therapeutic-Moleculeshttps://www.newsfilecorp.com/release/146207/NurExone-Biologic-Successfully-Demonstrates-its-PatentPending-Platform-Technology-for-Loading-Exosomes-with-Therapeutic-Molecules]https://www.newsfilecorp.com/release/146207/NurExone-Biologic-Successfully-Demonstrates-its-PatentPending-Platform-Technology-for-Loading-Exosomes-with-Therapeutic-Molecules[/url]
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities